Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations

Non-small-cell lung cancer (NSCLC) is the primary cause of cancer-related death. Gene rearrangements involving the anaplastic lymphoma kinase (ALK) tyrosine kinase identify a clinical and molecular subset of NSCLC patients, who benefit from the monotherapy with ALK tyrosine kinase inhibitors. Noneth...

Descripción completa

Detalles Bibliográficos
Autores principales: Canale, Matteo, Petracci, Elisabetta, Cravero, Paola, Mariotti, Marita, Minuti, Gabriele, Metro, Giulio, Ludovini, Vienna, Baglivo, Sara, Puccetti, Maurizio, Dubini, Alessandra, Martinelli, Giovanni, Delmonte, Angelo, Crinò, Lucio, Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253903/
https://www.ncbi.nlm.nih.gov/pubmed/35779323
http://dx.doi.org/10.1016/j.tranon.2022.101471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253903/
https://www.ncbi.nlm.nih.gov/pubmed/35779323
http://dx.doi.org/10.1016/j.tranon.2022.101471

Ejemplares similares